Patent · US Active

Magnetorheological formulation

US8486292B2 · kind B2 · utility

1Cited by
9References
19Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 18, 2007
Grant dateJul 16, 2013
Priority date
Expiry dateNov 27, 2028

Classification

  • Technology area (CPC H)Electricity
  • CPC primaryH01F1/447
  • WIPO fieldElectrical machinery, apparatus, energy
  • WIPO sectorElectrical engineering

Abstract

Magnetorheological formulations, processes for preparing the same and uses therefor, the formulations comprising: (a) an ionic liquid comprising anions and cations, and (b) dispersed magnetizable particles having a mean diameter of 0.1 to 500 μm; wherein the ionic liquid comprises one or more salts selected from the group consisting of 1-butyl-3-methyl-imidazolium methylsulfate, 1-ethyl-3-methylimidazolium ethylsulfate, 1-ethyl-3-methyl-imidazolium thiocyanate, 1-butyl-3-methylimidazolium thiocyanate, 1-ethyl-3-methyl-imidazolium acetate, 1-butyl-3-methylimidazolium acetate, 1-ethyl-3-methylpyridinium ethylsulfate, 1-ethyl-3-methylimidazolium dicyanamide, 1-butyl-3-methylimidazolium tetrafluoroborate, 1-hexyl-3-methylimidazolium tetrafluoroborate, 1-methyl-3-octylimidazolium tetrafluoroborate, 1-methyl-3-octylimidazolium hexafluorophosphate, 1-ethyl-3-methylimidazolium hexafluorophosphate, 1-hexyl-3-methylimidazolium hexafluorophosphate, methyltrioctylammonium bis(trifluoromethylsulfonyl)imide, 1-ethyl-3-methylimidazolium 2-(2-methoxyethoxy)ethylsulfate and mixtures thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.